VanEck Vectors Pharmaceutical ETF (PPH)

Add to Watchlists
Create an Alert
51.60 -0.31  -0.60% NASDAQ Jan 23, 13:52 Delayed 2m USD
View Full Chart
PPH Price Chart

PPH Key Stats

Expense Ratio 0.35%
Share Class Assets Under Management 274.49M
30-Day Average Daily Volume Upgrade
Net Asset Value 51.91
Discount or Premium to NAV 0.00
Turnover Ratio 25.00

PPH Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -0.96% 1.38% 89
3M -6.23% 0.03% 96
6M -14.64% -3.46% 97
1Y -17.79% 3.37% 98
3Y 1.59% 5.73% 97
5Y 10.11% 16.17% 99
As of Jan. 20, 2017
Returns for periods of 1 year and above are annualized.

PPH Asset Allocation

Type % Net % Long % Short
Cash 0.00 0.00 0.00
Stock 100.00% 100.00% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00% 0.00% 0.00
As of Jan. 19, 2017

PPH Region Exposure

Americas 68.81%
North America 68.81%
Latin America 0.00
Greater Europe 31.19%
United Kingdom 10.25%
Europe Developed 16.78%
Europe Emerging 0.00
Africa/Middle East 4.15%
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Jan. 19, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

PPH Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of Jan. 19, 2017

PPH Stock Market Capitalization

Giant 62.81%
Large 26.92%
Medium 9.45%
Small 0.83%
Micro 0.00
As of Jan. 19, 2017

PPH Stock Style Exposure

Large Cap Value 35.46%
Large Cap Blend 40.76%
Large Cap Growth 13.96%
Mid Cap Value 5.63%
Mid Cap Blend 2.14%
Mid Cap Growth 1.22%
Small Cap Value 0.40%
Small Cap Blend 0.43%
Small Cap Growth 0.00
As of Jan. 19, 2017
View More Holdings

PPH Top 10 Holdings

Symbol Name % Weight Price % Chg
JNJ Johnson & Johnson 10.37% 114.15 +0.00%
NVS Novartis AG ADR 7.53% 70.09 -0.79%
PFE Pfizer Inc 6.81% 31.48 -0.90%
MRK Merck & Co Inc 5.08% 61.90 -1.01%
GSK GlaxoSmithKline PLC ADR 5.02% 38.83 +0.28%
LLY Eli Lilly and Co 4.99% 76.38 -0.56%
ABBV AbbVie Inc 4.98% 60.77 -0.62%
BMY Bristol-Myers Squibb Company 4.89% 50.02 +1.60%
SNY Sanofi SA ADR 4.82% 40.15 -0.50%
AZN AstraZeneca PLC ADR 4.73% 27.00 -0.26%
As of Jan. 19, 2017
Advertisement

PPH One Page Reports

PPH Basic Info

Style
Equity Style Large Cap/Value
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name Van Eck
Benchmark Index
MVIS US Listed Pharmaceutical 25 NR USD
100.0%

PPH Manager Info

Name Tenure
George Chao 4.95 yrs
Hao-Hung (Peter) Liao 4.95 yrs

PPH Net Fund Flows

1M 5.236M
3M 54.28M
6M 31.34M
YTD -40.05M
1Y -40.05M
3Y -1.190M
5Y -57.81M
10Y --
As of Dec. 31, 2016

PPH Risk Info

Beta (5Y) 0.9076
Max Drawdown (All) 31.75%
Historical Sharpe (10Y) --
Historical Sortino (All) 1.260
30-Day Rolling Volatility 13.40%
Daily Value at Risk (VaR) 1% (All) 2.47%
Monthly Value at Risk (VaR) 1% (All) 9.30%

PPH Fundamentals

Dividend Yield TTM (1-23-17) 2.47%
SEC Yield (10-30-15) 1.82%
Weighted Average PE Ratio 24.98
Weighted Average Price to Sales Ratio 1.195
Weighted Average Price to Book Ratio 3.109
Weighted Median ROE 21.47%
Weighted Median ROA 7.03%
Forecasted Dividend Yield 2.70%
Forecasted PE Ratio 16.22
Forecasted Price to Sales Ratio 1.091
Forecasted Price to Book Ratio 2.915
Number of Holdings 26
As of Jan. 19, 2017

PPH Growth Estimates

Forecasted 5 Yr Earnings Growth 7.41%
Forecasted Book Value Growth 5.01%
Forecasted Cash Flow Growth 8.95%
Forecasted Earnings Growth 0.27%
Forecasted Revenue Growth 10.82%
As of Jan. 19, 2017

PPH Comparables

Edit

PPH Attributes

Key Dates
Inception Date 12/20/2011
Last Annual Report Date 9/30/2016
Last Prospectus Date 2/1/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

PPH Excel Add-In Codes

  • Name: =YCI("PPH","name")
  • Broad Asset Class: =YCI("PPH", "broad_asset_class")
  • Broad Category: =YCI("PPH", "broad_category_group")
  • Prospectus Objective: =YCI("PPH", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.